Viking Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Viking Therapeutics, Inc. (VKTX) reported Increase (Decrease) in Accounts Payable of $15.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-29
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.83M.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $13.93M.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $48.84M, a 410.80% increase year-over-year.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.08M.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $43.44M, a 1786.15% increase from fiscal 2024.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $2.30M.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$1.02M, a 114.37% decline from fiscal 2022.
- Viking Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $7.08M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $15.76M 10-Q · filed 2026-07-29 | $64.60M derived: sum of 3 quarters · filed 2026-07-29 | $63.52M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $13.93M 10-Q · filed 2026-04-30 | $62.77M derived: sum of 2 quarters · filed 2026-04-30 | $61.69M derived: sum of 3 quarters · filed 2026-04-30 | $59.48M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $48.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $47.76M derived: sum of 2 quarters · filed 2026-02-11 | $45.55M derived: sum of 3 quarters · filed 2026-07-29 | $43.44M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$3.29M derived: sum of 2 quarters · filed 2026-07-29 | -$5.40M 10-Q · filed 2025-10-23 | $4.16M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$4.32M 10-Q · filed 2026-07-29 | $5.24M derived: sum of 3 quarters · filed 2026-07-29 | -$5.59M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$2.11M 10-Q · filed 2026-04-30 | $7.45M derived: sum of 2 quarters · filed 2026-04-30 | -$3.38M derived: sum of 3 quarters · filed 2026-04-30 | $2.48M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.27M derived: sum of 2 quarters · filed 2026-02-11 | $4.59M derived: sum of 3 quarters · filed 2026-02-11 | $2.30M 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | -$10.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$4.97M derived: sum of 2 quarters · filed 2025-10-23 | -$7.26M 10-Q · filed 2025-10-23 | -$5.46M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $5.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $3.58M 10-Q · filed 2025-07-23 | $5.38M derived: sum of 3 quarters · filed 2026-02-11 | $5.48M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | -$2.29M 10-Q · filed 2025-04-24 | -$486.00K derived: sum of 2 quarters · filed 2026-02-11 | -$386.00K derived: sum of 3 quarters · filed 2026-02-11 | $1.43M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.90M derived: sum of 2 quarters · filed 2026-02-11 | $3.71M derived: sum of 3 quarters · filed 2026-02-11 | -$1.02M 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $1.91M derived: sum of 2 quarters · filed 2024-10-23 | -$2.82M 10-Q · filed 2024-10-23 | $2.57M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | -$2.92M 10-Q · filed 2024-07-24 | $2.47M derived: sum of 3 quarters · filed 2025-02-26 | -$495.00K derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$4.73M 10-Q · filed 2024-04-25 | $655.00K derived: sum of 2 quarters · filed 2025-02-26 | -$2.31M derived: sum of 3 quarters · filed 2025-02-26 | $646.00K derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.42M derived: sum of 2 quarters · filed 2025-02-26 | $5.38M derived: sum of 3 quarters · filed 2025-02-26 | $7.08M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$9.00K derived: sum of 2 quarters · filed 2023-10-25 | $1.70M 10-Q · filed 2023-10-25 | $308.00K derived: sum of 4 quarters · filed 2024-02-07 | ||||
| 2022-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $4.66M 10-Q · filed 2023-07-26 | $3.27M derived: sum of 3 quarters · filed 2024-02-07 | $1.89M derived: sum of 4 quarters · filed 2024-02-07 | ||||
| 2022-03-31 | $1.71M 10-Q · filed 2023-04-26 | $317.00K derived: sum of 2 quarters · filed 2024-02-07 | -$1.06M derived: sum of 3 quarters · filed 2024-02-07 | -$1.70M derived: sum of 4 quarters · filed 2024-02-07 | ||||
| 2021-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$2.77M derived: sum of 2 quarters · filed 2024-02-07 | -$3.40M derived: sum of 3 quarters · filed 2024-02-07 | -$2.54M 10-K · filed 2024-02-07 | ||||
| 2021-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | -$2.01M derived: sum of 2 quarters · filed 2022-10-26 | -$1.15M 10-Q · filed 2022-10-26 | $76.00K derived: sum of 4 quarters · filed 2022-10-26 | ||||
| 2021-06-30 | -$637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $223.00K 10-Q · filed 2022-07-27 | $1.45M derived: sum of 3 quarters · filed 2022-07-27 | $1.00M derived: sum of 4 quarters · filed 2022-07-27 | ||||
| 2021-03-31 | $860.00K 10-Q · filed 2022-04-27 | $2.09M derived: sum of 2 quarters · filed 2022-04-27 | $1.64M derived: sum of 3 quarters · filed 2022-04-27 | $1.76M derived: sum of 4 quarters · filed 2022-04-27 | ||||
| 2020-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $778.00K derived: sum of 2 quarters · filed 2022-02-09 | $905.00K derived: sum of 3 quarters · filed 2022-02-09 | $1.55M 10-K · filed 2022-02-09 | ||||
| 2020-09-30 | -$452.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$325.00K derived: sum of 2 quarters · filed 2021-11-03 | $325.00K 10-Q · filed 2021-11-03 | $668.00K derived: sum of 4 quarters · filed 2021-11-03 | ||||
| 2020-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $777.00K 10-Q · filed 2021-07-28 | $1.12M derived: sum of 3 quarters · filed 2021-07-28 | $1.34M derived: sum of 4 quarters · filed 2021-07-28 | ||||
| 2020-03-31 | $650.00K 10-Q · filed 2021-04-28 | $993.00K derived: sum of 2 quarters · filed 2021-04-28 | $1.21M derived: sum of 3 quarters · filed 2021-04-28 | $1.41M derived: sum of 4 quarters · filed 2021-04-28 | ||||
| 2019-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $562.00K derived: sum of 2 quarters · filed 2021-02-17 | $756.00K derived: sum of 3 quarters · filed 2021-02-17 | $1.47M 10-K · filed 2021-02-17 | ||||
| 2019-09-30 | $219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $413.00K derived: sum of 2 quarters · filed 2020-10-28 | $1.13M 10-Q · filed 2020-10-28 | $954.00K derived: sum of 4 quarters · filed 2020-10-28 | ||||
| 2019-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $910.00K 10-Q · filed 2020-07-29 | $735.00K derived: sum of 3 quarters · filed 2020-07-29 | $405.00K derived: sum of 4 quarters · filed 2020-07-29 | ||||
| 2019-03-31 | $716.00K 10-Q · filed 2020-04-30 | $541.00K derived: sum of 2 quarters · filed 2020-04-30 | $211.00K derived: sum of 3 quarters · filed 2020-04-30 | $1.04M derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$505.00K derived: sum of 2 quarters · filed 2020-02-26 | $324.00K derived: sum of 3 quarters · filed 2020-02-26 | -$508.00K 10-K · filed 2020-02-26 | ||||
| 2018-09-30 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $499.00K derived: sum of 2 quarters · filed 2019-11-05 | -$333.00K 10-Q · filed 2019-11-05 | -$301.00K derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$3.00K 10-Q · filed 2019-08-01 | $29.00K derived: sum of 3 quarters · filed 2019-08-01 | $204.00K derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | -$832.00K 10-Q · filed 2019-05-02 | -$800.00K derived: sum of 2 quarters · filed 2019-05-02 | -$625.00K derived: sum of 3 quarters · filed 2019-05-02 | -$1.09M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $207.00K derived: sum of 2 quarters · filed 2019-03-13 | -$259.00K derived: sum of 3 quarters · filed 2019-03-13 | $264.00K 10-K · filed 2019-03-13 | $263.51K 10-K · filed 2018-03-07 | |||
| 2017-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$291.00K derived: sum of 2 quarters · filed 2018-11-07 | $232.00K 10-Q · filed 2018-11-07 | $232.12K 10-Q · filed 2017-11-08 | $608.83K derived: sum of 4 quarters · filed 2018-11-07 | |||
| 2017-06-30 | -$466.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $57.00K 10-Q · filed 2018-08-09 | $57.15K 10-Q · filed 2017-08-09 | $433.82K derived: sum of 3 quarters · filed 2018-08-09 | $331.74K derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $523.00K 10-Q · filed 2018-05-09 | $522.93K 10-Q · filed 2017-05-10 | $899.83K derived: sum of 2 quarters · filed 2018-05-09 | $797.74K derived: sum of 3 quarters · filed 2018-05-09 | $750.48K derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $376.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $274.74K derived: sum of 2 quarters · filed 2018-03-07 | $227.48K derived: sum of 3 quarters · filed 2018-03-07 | $677.18K 10-K · filed 2018-03-07 | ||||
| 2016-09-30 | -$102.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$149.34K derived: sum of 2 quarters · filed 2017-11-08 | $300.36K 10-Q · filed 2017-11-08 | $382.31K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | -$47.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $402.45K 10-Q · filed 2017-08-09 | $484.40K derived: sum of 3 quarters · filed 2017-08-09 | $577.25K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $449.70K 10-Q · filed 2017-05-10 | $531.65K derived: sum of 2 quarters · filed 2017-05-10 | $624.50K derived: sum of 3 quarters · filed 2017-05-10 | $631.63K derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $81.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $174.80K derived: sum of 2 quarters · filed 2017-03-21 | $181.93K derived: sum of 3 quarters · filed 2017-03-21 | $219.24K 10-K · filed 2017-03-21 | ||||
| 2015-09-30 | $92.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $99.98K derived: sum of 2 quarters · filed 2016-11-10 | $137.29K 10-Q · filed 2016-11-10 | $243.57K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $7.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $44.44K 10-Q · filed 2016-08-11 | $150.72K derived: sum of 3 quarters · filed 2016-08-11 | -$12.82K derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $37.31K 10-Q · filed 2016-05-10 | $143.59K derived: sum of 2 quarters · filed 2016-05-10 | -$19.95K derived: sum of 3 quarters · filed 2016-05-10 | $112.75K derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $106.28K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$57.25K derived: sum of 2 quarters · filed 2016-03-08 | $75.44K derived: sum of 3 quarters · filed 2016-03-08 | $191.01K 10-K · filed 2016-03-08 | ||||
| 2014-09-30 | -$163.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$30.84K derived: sum of 2 quarters · filed 2015-11-05 | $84.73K 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | $132.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $248.26K 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | $115.56K 10-Q · filed 2015-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |